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Résumé  
Introduction 
L’ostéogenèse imparfaite (OI) est un désordre de collagène héréditaire caractérisé par du tissu 
conjonctif défectueux et dont l'incidence est de 1 sur 20 000 naissances. Il y a une 
surreprésentation marquée de malocclusion de Classe III et d'occlusion croisée antérieure et 
postérieure dans la population d’OI. L’objectif principal de cette recherche est d’évaluer si la 
sévérité des malocclusions présentes chez les patients atteints d’OI est proportionnelle à la 
gravité du syndrome. L’objectif secondaire de cette recherche est d’évaluer si la sévérité de la 
malocclusion augmente avec l’âge. 
Matériels et méthodes 
Cette étude rétrospective observationelle fut effectuée par calcul du Discrepancy Index (DI) de 
56 modèles dentaires de patients atteints d’OI. Les résultats du DI ont été comparés à trois 
variables qui caractérisent la gravité du syndrome: le type de OI, le type génétique et le z-
score de la grandeur de chaque patient. En outre, l’analyse longitudinale d’un sous-ensemble 
de 20 modèles a été faite pour déterminer si la sévérité de la malocclusion augmente avec le 
temps. 
Résultats 
La médiane du DI était de 33,5 [1, 109]. Le DI est plus augmenté chez les patients atteints 
d’un type de OI plus sévère (p = 0,001) ainsi que chez les patients avec un z-score de grandeur 
plus petit (p <0,0001).  L'analyse longitudinale a démontré une augmentation statistiquement 
significative du DI au fil du temps (p=0.05). 
Conclusion 
La malocclusion des patients atteints d’OI semble liée à la gravité de ce syndrome. En outre, la 
sévérité de la malocclusion semble augmenter avec l’âge. 
 
Mots-clés: ostéogenèse imparfaite, malocclusion, Discrepancy Index 
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Abstract 
Introduction: Osteogenesis imperfecta (OI) is an inherited collagen disorder characterized by 
defective connective tissue with an incidence of 1 in 20,000 births. There is a marked over-
representation of Class III malocclusion, negative overjet and lateral openbite in the OI 
population. 
 
Objectives: Primary objective is to evaluate whether the severity of the malocclusions present 
in OI patients is proportional to the severity of the syndrome.  Secondary objective is to 
evaluate whether the malocclusion severity increases with age. 
 
Methods: Retrospective observational study performed by calculating the Discrepancy Index 
(DI) of 56 dental casts of patients with mild to severe OI.  DI scores were compared to three 
variables that characterize the severity of the syndrome: OI type, genetic type and height z-
score of each patient. In addition, longitudinal analysis of a subset of 20 OI casts was done to 
determine whether the malocclusion increases in severity with time. 
 
Results: The median DI score was 33.5 [1, 109].  The DI score increased with increasing 
severity of OI type (p=0.001) and decreasing height z-score (p<0.0001). In addition, 
longitudinal analysis of 20 OI patients demonstrated a statistically significant increase in DI 
over time (p=0.05). 
 
Conclusion: The malocclusion characteristic of OI patients seems linked to the severity of the 
syndrome. In addition, the malocclusion severity seems to increase with age.  
 
Keywords: Osteogenesis imperfecta, malocclusion, Discrepancy Index 
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Introduction 
Osteogenesis Imperfecta 
Overview 
Osteogenesis Imperfecta (OI) is a complex genetically inherited disorder characterized by 
defective connective tissue with an incidence of 1 for every 20 000 births. [1] This 
heterogeneous disorder has been categorized into types from I to VII, based on clinical, 
radiographic and genetic criteria. [2, 3] Within these seven types, the pattern of heredity can 
be autosomal dominant or recessive; however, the genes that cause this syndrome always 
affect the primary structure of Type I collagen or alter the pathway of its production. [4] 
Consequently, individuals born with OI have increased bone fragility and low bone mass. 
These patients are susceptible to spontaneous bone fractures and may show a number of other 
defects, such as joint laxity, hearing impairments, malformed long bones, growth deficiency, 
muscle weakness, blue sclera, dentinogenesis imperfecta and/or dental malocclusion.  The 
severity of these clinical manifestations is widely variable, ranging from mild forms with no 
apparent features and perinatal death. [2] 
 
Pathogenesis 
OI is a connective tissue disorder characterized by a hereditary defect in the production of 
Type I collagen. [2, 5] Collagen is the most abundant protein in the body and serves as the 
major extracellular component of bone. [6] It is also found in the skin, connective tissue, blood 
vessel walls, sclera, cornea of the eye, etc. [7] Although this protein is found throughout the 
body, there are different types of collagen and their structural differences are based on their 
role in each organ. [7, 8]  
Type I collagen has a particular structure that is extremely important for proper 
functioning. This fibrous protein is initiated as procollagen, a triple helical molecule of three 
intertwined polypeptide chains, two pro-α1 chains and one pro-α2 chain. [6, 9] (Figure 1) 
These chains are composed of a repeating amino acid sequence, with the most important 
feature being a glycine molecule in every third position.  Glycine, the smallest amino acid, is 
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essential since its small shape allows for the three pro-α polypeptide to join together as a well 
bound pro-collagen triple helix. [2, 5, 7, 10-12]  
 
 
Figure 1: Mechanisms contributing to autosomal dominant osteogenesis imperfecta bone dysplasia: from mutant 
type I collagen gene to bone defect. [4] 
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This triple helix is then exported to the endoplasmic reticulum where it is modified extensively 
by hydroxylation and glycosylation. [6] For example, cartilage-associated protein (CRTAP), 
cyclophilin B (CyPB) and prolyl 3-hydroxylase (P3H1) come together as collagen 3-
hydroxylation complex in order to hydroxylate the proline amino acid in each polypeptide 
chain and adequately fold the pro-collagen helix.  [4, 9] The N- and C- propetides are then 
cleaved in the extracellular space, which then allows the mature tropocollagen molecules to 
assemble together and form collagen fibrils. [6]  
Since type I collagen is the main protein in bone extracellular matrix, any aberrations 
in its synthesis can create an OI phenotype. [2, 6] Once a deficient collagen molecule is 
produced, it will either be degraded or incorporated into the body’s structures. The former will 
create a quantitative defect, while the latter will create a qualitative one.  Defective 
tropocollagen protein secreted into the cell matrix not only affects fibrillogenesis and bone 
mineralization, but also cell-to-cell communication. [4, 11] In fact, the OI phenotype created 
by the various genetic mutations will depend on which protein structures are affected and 
which organs harbor these proteins. [13]    
 
Inheritance  
Over 800 mutations in the Type I collagen genes have been linked to the OI syndrome. [5, 11] 
The majority of patients (90%) with OI have an autosomal dominant mutation in the COL1A1 
gene on chromosome 17 or COL1A2 gene on chromosome 7. [6, 9, 14] These genes encode 
the amino acid sequence in the pro-α1 chains and pro-α2 chains respectively. [2, 4, 6, 9, 10, 
15] DNA mutations at these sites alter the structure and/or quantity of Type I collagen in the 
affected individual and the severity will range from clinically undetectable to lethal.  [4] In 
addition to autosomal dominant forms of OI, there are autosomal recessive inheritance 
patterns that have also been discovered. [4, 6] 
Type I OI, the mildest and most common form of the disease, is produced via a 
premature stop codon in the COL1A1 gene.  The mRNA produced by the mutated allele will 
be degraded by nonsense-mediated decay, which leads to a haploinsuffuciency and diminishes 
the total amount of Type I collagen in the body. [2, 5, 11, 12] The result is a mild phenotype of 
the syndrome characterized by minimal bone fragility, blue sclera and hearing loss.  [5, 9, 10]  
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Types II, III and IV, are caused by mutations leading to a distorted three-dimensional 
structure of type I procollagen. [5] The most common type of DNA mutation changes the 
amino acid sequence by substituting the obligatory glycine molecule for a bulkier amino acid. 
[2, 12]  This substitution will impair the triple helical folding mechanism, as well as post-
translational hydroxylation and glycosylation. In addition, improper splicing, deletions and 
insertions have also been discovered as other types of possible mutations. [6] Consequently, 
the amino acid sequence of the procollagen protein is altered which produces a less functional 
Type I collagen molecule.  Mutations in the COL1A1 genes are more commonly lethal, 
whereas mutations in COL1A2 genes are 80% non-lethal. [5, 11]  
In recent years, more types of OI have been discovered and added to the classification 
system.  OI Types V, VI and VII are typically recessive in autosomal inheritance and usually 
produce severe phenotypes of the disease. [4, 6] 
 
Clinical manifestations 
The OI syndrome has a very broad phenotypic range. Patients with the same type of OI will 
present with different clinical manifestations and varying degrees of severity.   
 
Bone Fragility 
Bone fragility is the principal clinical characteristic in the OI syndrome, with its severity 
increasing in the following order: Type I < Type IV, V, VI, VII < Type III < Type II. [2, 16] 
Due to the abnormal collagen production, there are several disturbances in the organic and 
mineral compounds of the body, and these changes have a deleterious effect on bone mass, 
strength and stiffness. [2, 4, 16] The bone that is formed has an abnormal and irregular 
morphology, as well as an increased mineral density. [2, 4]  Consequently, OI bone breaks 
much more easily when deformed even though the increased mineralization makes it harder in 
consistency. [2, 17] Furthermore, histomorphometric analysis of bone from OI patients 
revealed an increased number of osteoclasts and osteoblasts, an overall increase in the rate of 
bone formation, but a decreased volume of trabecular and cancellous bone volume.  [2, 12, 16] 
(Figure 2) There is a reduction in bone volume because although there is an increase in the 
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number of osteoblasts, each OI osteoblast secretes less bone than normal and bone resorption 
is amplified by the simultaneous increase in osteoclast numbers. [2, 4, 12, 16]  
 
 
Figure 2: “Summary of histological bone abnormalities in OI : Osteogenesis imperfecta bone has a smaller than 
normal external size (bone thickness) because of sluggish periosteal bone formation.  Trabeculae are reduced in 
number and are abnormally thin.  Although individual osteoblasts produce less bone than normal, the overall 
bone formation rate in the trabecular compartment is amplified, because the number of osteoblasts is raised.  
However this increase does not lead to a net gain in trabecular bone mass, because the activity of bone resorption 
is also enhanced.” [2] 
 
 
Consequently, the skeleton is more fragile and it fractures much more easily.  There is an 
increase in number of lower limb fractures, deformity and bowing of long bones and scoliosis 
caused by vertebral crush fractures. [2, 9] (Figure 3) 
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Figure 3: “Bowing of the radius (a) and tibia (b) in a baby with OI type III” [10] 
 
Growth 
A decrease in height is one of the chief clinical characteristics in patients with OI. [4, 6, 18] 
Even children with OI Type I, who seem to be in the normal range, are often below the 50th 
percentile range. [6, 9] Patients with the more severe Type III OI have a very short stature, 
typically within 90 to 120 cm. [10] (Figure 4) In fact, Jensen & Lund have demonstrated that 
height is significantly reduced in patients with the more severe phenotypes of the disease, 
which suggests that height is a predictor of disease severity in the OI syndrome.  [18] 
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Figure 4: Female with short stature and scoliosis; height = 93cm. [19] 
 
Hearing Loss 
Hearing loss is a common secondary feature in individuals with an autosomal dominant form 
of OI, which affects about 50% of adult patients. [20] This condition is caused by a 
combination of conductive and sensorineural defects and usually manifests itself between the 
second and fourth decade of life. [4, 6, 20]  However, about 5% of children with OI have been 
found to show signs of early-onset hearing loss. Kuurila et al. recommend an audiometrical 
analysis be performed in children with osteogenesis imperfecta even without symptoms of 
hearing loss starting at the age of 10 years, with a repetition every 3 years. [20] No cases of 
hearing defects have been reported in patients with a recessive form of OI. [6] 
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Blue Sclera 
Blue sclera is caused by abnormal collagen fibers in the sclera, which create the characteristic 
blue hue of the cornea. [21] Not all patients with OI present with blue sclerae.  In cases of 
those who do, the scleral hue is variable. In Type I and Type III OI, blue sclerae are present at 
birth and persist throughout life, whereas in Type IV, the scleral hue becomes progressively 
normal with age. (Figure 5)  In the perinatal-lethal form of OI, the sceral hue is often the 
darkest, sometimes even reaching a shade of black. [9] 
 
 
Figure 5: Blue Sclera [14] 
 
Oral Manifestations 
There are several oral manifestations within the OI syndrome, the most widely reported 
feature being dentinogenesis imperfecta.  Dentinogenesis imperfecta is a dental pathology 
characterized clinically by an amber-brown to blue grey opalescent hue of the teeth, 
thin/cracking enamel and severe attrition.  (Figure 6) The radiographic findings include short 
roots, bulbous crown structure, obliteration of the pulp chamber and frequent peri-radicular 
radiolucencies. [22-24] The primary dentition is often affected more severely than the 
permanent dentition. [23, 25] Approximately 80% of patients with autosomal dominant OI 
have dentinogenesis imperfecta, but it is extremely rare in autosomal recessive types of OI. [6, 
23, 26] 
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Figure 6: Dentinogenesis imperfecta of primary dentition (courtesy of the Montreal Children’s Hospital) 
 
Many authors have described dentinogenesis imperfecta in detail, but very few have 
documented another important facet of the OI syndrome: the dental malocclusion. A study by 
Rizkallah et al. in 2012 revealed that the malocclusions present in the OI population are more 
severe than those present in the general population. They confirmed that there is a distinct 
over-representation of Class III malocclusion, negative overjet and lateral openbite in patients 
with OI. [27] (Figure 7) 
 
 
Figure 7: OI patient exhibiting Class III malocclusion, anterior openbite, lateral posterior crossbite and opalescent 
teeth [27] 
 
Diagnosis  
The diagnosis of OI is usually done on a clinical basis.  It is often clear in individuals with a 
positive family history in whom several cardinal manifestations are present.   However, it can 
be quite difficult when other family members are unaffected and bone fragility is the only 
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indication of the syndrome. In addition, there is no agreed minimum number of criteria that 
can establish a clinical diagnosis of the syndrome.  [2] Thus, practitioners typical rely on a 
complete clinical examination as well as genetic work-up to establish a diagnosis of the 
disease.   DNA analysis of the genes involved in the biosynthesis of Type I collagen can be 
performed and are highly sensitive. [2, 9]  However, results that do not detect a genetic 
mutation in COL1A1, COL1A2, CRTAP and SERPINF1 do not rule out a diagnosis of OI. [2] 
 If a diagnosis of OI seems possible but is inconclusive with a mere clinical exam and 
genetic analysis, other analyses can be done. Radiographs can detect bowing of the long 
bones, presence of crush vertebral factures and scoliosis. [9] Bone histomorphometry can help 
distinguish OI from other osteoporotic conditions. In addition, when polarized light 
microscopy is used, OI types V and VI can be diagnosed. [2, 9]  (Figure 8) However, this 
invasive method is usually avoided whenever possible since it depends upon a bone biopsy 
retrieved under general anesthesia. [9]   
 
 
Figure 8: “Bone lamellation pattern as seen under polarized light (A) Healthy control. (B) OI type I; lamellae are 
thinner than normal, but lamellation is smooth. (C) OI Type III; lamellation is slightly irregular. (D) OI type IV; 
lamellation is similar to type III disorder. (E) OI type V; mesh-like pattern. (F) OI Type VI; fish-scale pattern.” 
[2] 
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There are a variety of differential diagnoses available for OI, which depend on the age 
of presentation, clinical manifestations and the severity of the signs and symptoms. [9] 
(summarized in Table 1) 
 
Table 1: Differential diagnosis of osteogenesis imperfecta [2, 9] 
Condition Childhood phenotype Inheritance Pathophysiology 
 
Non-accidental 
injury 
Multiple unexplained childhood 
fractures 
 
-- Pathologic fractures 
Bruck syndrome Moderate to sever. Congenital joint 
contractures; scoliosis; white 
sclerae 
 
AR 
 
Deficiency of 
telopeptide lysyl 
hydroxylase 
 
Cole-Carpenter 
syndrome 
Severe. Normal at birth; short 
stature; osteoporosis; diaphyseal 
fractures; hydrocephalus; ocular 
proptosis; distinctive facial features 
 
Uncertain No abnormality of 
type I collagen 
Hypophosphatasia Mild to severe. Low alkaline 
phosphatase activity; very variable 
clinical expression; early loss of 
teeth 
 
AD/AR Mutation in ALPL 
Idiopathic 
hyperphosphatasia 
or juvenile Paget 
disease 
Severe. Raised alkaline phosphatase 
activity; very variable phenotype; 
thickened skull; widened diaphysis; 
progressive deformity; scoliosis; 
deafness 
AR Osteoprotegerin 
deficiency due to 
mutation in 
TNFRSF11B in the 
majority of cases 
 
Panostotic fibrous 
dysplasia 
Sever. Characteristic lesions in all 
bones. 
Somatic  Somatic mutation in 
GNAS 
 
Osteoporosis 
pseudoglioma 
syndrome 
 
Moderately severe. Congenital 
blindness; torus palatinus 
AR Mutation in LRP5 
Idiopathic juvenile 
osteoporosis 
Mild to moderately sever. Transient 
osteoporosis; prepubertal 
presentation; metaphyseal fractures; 
neo-osseous osteoporosis; no 
extraskeletal manifestations 
Uncertain Unknown etiology in 
the majority of cases; 
sometimes associated 
with heterozygous 
mutation in LRP5 
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Classification 
The classification of OI has proven to be quite difficult, given that the syndrome is highly 
heterogeneous. In 1979, Sillence et al. categorized OI patients into four types based on clinical 
presentation. [28] In recent years, there has been further subdivision of these four types 
according to genetic factors and bone histology techniques. (Table 2) [2, 3] Presently, eleven 
types of OI have been described. [4, 9] These subdivisions are mainly based on differences in 
the genetic factors leading to the disease, even though the clinical phenotype may be very 
similar to the pre-existing OI types.  In other words, OI Type V, VI and VII are very often 
clinically undistinguishable from OI Type IV. [29] Some authors have stated that this 
intermingling of genetic and clinical classification is very confusing and problematic. [6, 29] 
For the purpose of simplicity, the classification system used in this paper will be from The 
Lancet’s 2004 seminar on osteogenesis imperfecta. [2] 
 
Table 2: Expanded Sillence classification of osteogenesis imperfecta [2-4, 6, 9] 
Type Clinical 
severity 
Mode of 
inheritance 
Typical features Typically 
associated 
mutations* 
I Mild non-
deforming 
osteogenesis 
imperfecta 
AD Normal height or mild short 
stature; blue sclera; no 
dentinogenesis imperfect 
Premature 
stop codon 
in COL1A1 
II Perinatal 
lethal 
AD Multiple rib and long-bone 
fractures at birth; pronounced 
deformities; broad long bones; 
low density of skull bones on 
radiographs; dark sclera 
 
Glycine 
substitutions 
in COL1A1 
or COL1A2 
III Severely 
deforming 
AD Very short; triangular face; severe 
scoliosis; greyish sclera; 
dentinogenesis imperfect 
Glycine 
substitutions 
in COL1A1 
or COL1A2 
IV Moderately 
deforming 
AD Moderately short; mild to 
moderate scoliosis; grayish or 
white sclera; dentinogenesis 
imperfecta 
 
Glycine 
substitutions 
in COL1A1 
or COL1A2 
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V Moderately 
deforming 
AR? Mild to moderate short stature; 
dislocation of radial head; 
distinctive histology; mineralised 
interosseous membrane; 
hyperplastic callus; white sclera; 
no dentinogenesis imperfecta 
 
Unknown 
VI Moderately 
to severely 
deforming 
AR Moderately short; scoliosis; 
accumulation of osteoid in bone 
tissue, fish-scale pattern of bone 
lamellation; white sclera; no 
dentinogenesis imperfecta 
Homozygous 
SERPINF1 
mutations 
VII Moderately 
deforming 
AR Mild short stature; short humeri 
and femora; white sclera; no 
dentinogenesis imperfecta 
Homozygous 
CRTAP 
mutations 
*May or may not be detectable in a given patient 
 
Treatment 
The medical management of patients diagnosed with OI is a multidisciplinary approach that 
combines physical therapy, orthopedic surgery and pharmacotherapy.   Treatments are usually 
focused on improving functional ability by decreasing bone fragility and increasing mobility 
in patients with more severe OI phenotypes. [30, 31] The key to successfully treat these 
patients is to combine a multidisciplinary approach with early diagnosis.  [5, 31] 
 
Physical Therapy 
The primary goal of physical therapy is to improve motor function and reduce immobility-
induced bone-loss. [30] Many children with severe phenotypes of OI have very limited 
mobility and are often wheelchair-bound. These patients benefit greatly from physical therapy, 
especially in the lower extremities. 
 
Orthopedic surgery 
Orthopedic surgery is very common in the treatment of severe OI phenotypes. Surgical 
intervention often consists of the placement of intramedullary rods in the long bones to correct 
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deformities and stabilize the bone.  [4, 30] This kind of corrective surgery enables walking and 
improves overall mobility in OI patients. [4] 
 
Pharmacotherapy 
Pharmocotherapy is currently the most widely used medical intervention for children with 
moderate to severe OI. [10] The ultimate goal is to reduce fracture numbers, prevent long bone 
deformities and increase functional mobility. [2] The most popular medication used today are 
bisphosphonates, but new advances in the use of recombinant human growth factor have also 
been made in recent years. [13] 
Bisphosphonates have an inhibitory effect on osteoclasts and therefore, decrease bone 
resorption. [2, 10, 13, 31] When treated with this medication, the quality of the new bone 
formed does not improve, but the skeleton does benefit from an increase in bone volume and 
an overall increase in mechanical strength. [10, 31] The most popular bisphosphonate used 
today is cyclic intravenous pamidronate, given in cycles of three days every two to four 
months. [2, 10] In a study by Glorieux et al. in 1998, more than 50% of the OI patients treated 
with cyclic pamidronate had an improvement in mobility, as well as a decrease in overall 
fracture rate. [31] In the moderate to severe OI phenotypes, bisphosphonate therapy should be 
started as early as possible in order to benefit from the growth process.  On the other hand, 
mild forms of OI should not receive bisphosphonate therapy as the negative side effects 
(abnormal bone metabolism, risk of osteonecrosis, etc.) may outweigh the benefits of this 
treatment modality. [2, 10, 13]  
Growth hormone has also been studied in the past as a treatment for the OI syndrome, 
given that short stature is one of its more common features. [32] In a study in 2003, Marini et 
al. revealed that the baseline growth rate of about 50% of the OI patients treated with 
recombinant human growth hormone doubled during the first year of treatment. [4, 33] This 
study also showed that bone turnover rates were increased, a secondary effect that is 
potentially harmful to OI patients. [33] For this reason, it is probably beneficial to combine 
recombinant human growth hormone with bisphosphonate therapy, but this treatment still 
needs to be adequately investigated in the future. [2, 10, 13, 33]  
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Conclusion  
Osteogenesis imperfecta  (OI) is a complex genetically inherited disorder characterized by 
defects in biosynthesis of Type I collagen. Consequently, individuals affected by OI are 
susceptible to spontaneous bone fractures, long bone deformities, short stature, hearing 
impairments, muscle weakness, blue sclera, dentinogenesis imperfecta and/or dental 
malocclusion.  [2] It is well known that the OI syndrome is caused by alterations in the 
collagen type I biosynthesis pathway, but the exact mechanism by which the genetic defects 
cause abnormal bone formation have not been described. [16] A better understanding of the 
disease pathway and the resulting phenotypic expression can aid in the diagnosis, 
classification and the efficient treatment of this debilitating disease. Great advances have been 
made in the understanding of the OI syndrome and the help that is now available to these 
patients is extensive; however, the morbidity of the more severe phenotypes is still astounding. 
No cure for the disease has been found, so more must be done in order to optimize their 
mobility, autonomy and quality of life. [10, 13]  
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Malocclusion 
Overview 
The study of orthodontics and the treatment of malocclusion have become increasingly 
popular in the last century.  However, malocclusion has been a part of human history since 
antiquity and attempts at correcting misaligned, protruding, and irregular teeth have been 
documented since 1000 B.C.  Dentistry has come a long way since the 18th and 19th centuries, 
and the same is true for orthodontics, the branch of dentistry focused on correcting 
malocclusion.  In the 1890’s, Edward H. Angle, the so-called “father of orthodontics”, 
subdivided the major types of malocclusion and proposed a classification system that is still 
widely used today. [34] 
 
Classification 
A classification system proposed by Angle was based on the position of the upper first molar.  
Angle believed that in order to have a normal occlusion, two cardinal features must be present. 
First, the mesiobuccal cusp of the upper first molar must occlude with the buccal groove of the 
lower molar (Figure 9) and second, all the teeth must be arranged on a standard smoothly-
curving line of occlusion. [34] (Figure 10) 
 
 
 
Figure 9: Mesiobuccal cusp of upper first molar occludes with buccal 
groove of lower first molar  [34] 
 
                                                                                    Figure 10: Upper and lower lines of occlusion [34] 
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Angle then described three distinct classes of malocclusion based on aberrations in the two 
previous features. 
 
Class I Malocclusion 
Mesiobuccal cusp of upper first molar occludes with buccal groove of the lower first molar, 
but the teeth are not well aligned on the line of occlusion. (Figure 11) 
 
 
Figure 11: Class I malocclusion [34] 
 
Class II Malocclusion 
Mesiobuccal cusp of upper first molar positioned mesial relative to the lower first molar; teeth 
may or may not be well aligned on the line of occlusion. (Figure 12) 
 
 
Figure 12:Class II malocclusion [34] 
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Class III Malocclusion 
Mesiobuccal cusp of upper first molar positioned distal relative to the lower first molar; teeth 
may or may not be well aligned on the line of occlusion. (Figure 13) 
 
 
Figure 13: Class III malocclusion [34] 
 
Class I malocclusions (69.7%) are the most common, followed by Class II malocclusions 
(23.8%) and finally, a small number of the population possess a Class III malocclusion (6.5%). 
[34-36] Many studies have been done on the incidence of malocclusion in different 
populations. The previous percentages are limited to the American Caucasian population. [36] 
 
Terminology 
Other important features of a malocclusion that are not part of Angle’s classification system 
are as follows: anterior and posterior crossbites, anterior and posterior openbites, increased 
overbite and increased overjet. 
 
Overjet 
Overjet is the horizontal measurement between the maxillary and mandibular incisors. (Figure 
14) A normal overjet is typically 2mm when measuring from the labial surface of the 
mandibular incisor to the labial surface of the maxillary incisor. A negative overjet or anterior 
crossbite will result if the mandibular incisors are anterior to the maxillary incisors. [34] 
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Figure 14: Overjet between the maxillary and mandibular incisors [34] 
 
A posterior crossbite would result if the posterior overjet is reversed.  More specifically, to 
have a posterior crossbite, the maxillary posterior teeth would be positioned more lingual than 
the mandibular posterior teeth.  A posterior crossbite can be unilateral or bilateral.    
 
Overbite 
Overbite is the vertical measurement between the upper and lower incisors. (Figure 15) 
Normally, the maxillary incisors overlap the mandibular teeth by 2mm.  [34] 
 
 
Figure 15: Overbite between the maxillary and mandibular incisors [34] 
 
When a space exists between the maxillary and mandibular teeth, this is referred to as an 
openbite. (Figure 16)  An openbite can be anterior, posterior, unilateral or bilateral.   
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32 
 
 
Figure 16: The presence of an anterior openbite [34] 
 
In order to make Angle’s classification more complete, Mills suggested the addition of 
more information as an aid in describing the various malocclusions that exist. (Summarized in 
Table 3) [35] 
 
  Table 3: Expanded Angle Classification [35] 
Class Type Clinical Characteristics 
I I Crowded incisors; the canines are frequently labial 
 II Protrusion or labioversion of the maxillary incisors 
 III Presence of anterior crossbite 
 IV Presence of posterior crossbite 
 V Mesial drifting of molars resulting from premature loss of 
teeth 
II Division 1 Proclined maxillary incisors (labioversion) 
 Division 2 Retroclined maxillary central incisors 
III I Maxillary and mandibular teeth in good alignment, but 
incisors in edge-to-edge occlusion 
 II Maxillary teeth in good alignment, mandibular teeth 
crowded; mandibular incisors lingual to maxillary teeth 
 III Maxillary teeth crowded, mandibular teeth in good 
alignment; mandibular incisors labial to maxillary incisors 
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Etiology  
As previously stated, Angle’s classification of the 3 types of malocclusion is highly simplified.  
He fails to take into account several important components critical in assessing the etiology of 
the malocclusion, which are: “(a) the size of the maxilla, (b) the size of the mandible, body 
and ramus, (c) the factors that determine the relationship between the maxilla and mandible, 
which are genetic and environmental, (d) the arch form, (e) the size and morphology of the 
teeth, (f) the number of teeth present, and (g) the soft tissue morphology.” [37] 
A malocclusion can have a skeletal etiology, a dentoalveolar etiology, or a 
combination of the two.  A skeletal malocclusion is one in which there is an aberrant 
relationship between the maxilla, mandible and/or cranial base. A dentoalveolar malocclusion 
can be due to an abnormal arch form, abnormal tooth size and/or missing teeth.  All 
malocclusions result from a combination of genetic and environmental factors which affect 
craniofacial growth, arch size, tooth size, tooth loss, etc. [34, 37] Diagnosing the etiology of 
the malocclusion is essential in providing the best treatment. 
 
Severity 
Angle’s “normal occlusion” is actually quite rare in the human population and should be 
considered as the ideal. [34] Furthermore, great variability exists when measuring the 
incidence of malocclusion in our society.  There are several reasons for the lack of consensus; 
there is a wide divergence in the definition of a normal and abnormal occlusion, the presence 
of diagnostic error and a lack of a universal index. [35] In recent years, several indices have 
been developed to assess the presence and severity of the malocclusions in the general 
population.  The American Board of Orthodontics uses the discrepancy index. [38] 
The discrepancy index (DI) is used as a means of quantifying the severity of 
malocclusions.  Normally, assessing a malocclusion can be very subjective.  With the use of 
the discrepancy index, various easily measured clinical components are tabulated to give an 
overall severity score. Cephalometric radiographs, panoramic radiographs and dental casts 
with a proper bite registration are needed in order to take measurements of the following: 
overjet, overbite, open bite, crowding, occlusal relationship, crossbite, presence of missing 
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teeth, and several cephalometric values.  The more the measurements differ from ideal in each 
component category, the greater the complexity and severity of the overall malocclusion. [38] 
 
Treatment  
The presence of a malocclusion does not necessarily mean that the individual requires 
treatment.  When assessing malocclusion, the discrepancy index can be very useful in 
quantifying the severity and difficulty expected for the orthodontist.  An orthodontic treatment 
is usually reserved for the more severe malocclusions or when patients are not content with 
their oral functions and/or dental esthetics.  There are several treatment modalities available 
when correcting a malocclusion based on its severity and etiology.  The three main options 
are: traditional orthodontics, orthognathic surgery and a combination of the two.  
Osteodistraction can also be used in severe craniofacial anomalies when surgical movements 
will be extreme.  
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Malocclusion in patients with osteogenesis imperfecta 
Overview 
Osteogenesis imperfecta is a syndrome that has been characterised with a high prevalence of 
malocclusion. [26, 39] Several authors have reported an increased development of Class III 
molar relationships, posterior and anterior openbites, crossbites and impacted teeth. [25-27] 
The precise etiology of the malocclusion is not yet known; however, it seems that the 
abnormal craniofacial growth present in OI patients results in aberrations in the relationship of 
the upper and lower jaws, dental arches and teeth. [40-43] Several authors have reported that 
the more severe phenotypes of OI seem to produce the more severe craniofacial abnormalities, 
but this hypothesis does not always seem to be true and merits an investigation. [18, 25, 40] 
Mild forms of OI are often very hard to diagnose and an investigation of the dental 
malocclusion may prove to be a cardinal diagnostic aid. [23, 44] 
 
Clinical characteristics 
Considerable variation exists in the expression of the dental phenotype within the different 
types of OI. [25] A different combination of dental characteristics and severity will be present 
in each individual and the reasons for these differences are still unknown.  Although, there is 
considerable variation, there are several craniofacial and dentoalveolar features that have a 
high prevalence in patients with OI. 
 
Craniofacial features 
Patients with OI usually have a triangular-shaped face, a broad forehead, macrocephaly and 
basilar invagination. [19, 26, 45] (Figure 17) 
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Figure 17: Patient with OI exhibiting a triangular shaped face, broad forehead and midface hypoplasia [45] 
 
Due to these changes in growth and associated abnormal posture, panoramic and 
cephalometric radiographs may be very difficult to obtain. [46] There seems to be a higher 
incidence of craniofacial disproportion in Types III and IV than in Type I. [18, 43, 45] 
Nevertheless, facial bones were found to be smaller than normal in all types of the syndrome. 
[43] More specifically, vertical facial dimensions, maxillary and mandibular lengths and the 
anterior/posterior cranial base lengths are all significantly shorter in OI patients. [41] The high 
proportion of Class III skeletal malocclusion is characterized primarily by midface hypoplasia.  
[25, 41-43]  According to Waltimo-Siren et al,  “the growth deficiency was more pronounced 
in the severely affected patients than in those with type I OI”. [43] 
 
Dentoalveolar characteristics 
Dental malocclusion is very common in patients with OI and has proven to be significantly 
more severe than that found in the general population. [27] There is an increased presence of 
Class III malocclusions, further compounded by a negative overjet, posterior crossbites and 
lateral openbites. [25-27] 
 The incidence of Class III molar occlusions in the OI population is elevated and has 
been found to range from 9.6-80%. [25, 26, 41, 47] The large range in these studies can be 
explained by the variability in phenotypic severity seen between the OI types.  Most studies 
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have found the incidence of Class III malocclusion to be closer to 62.5%-80%, which is 
significantly greater than the 6.5% previously found in the general population. [25, 26, 35, 36, 
41] The only study with a 9.6% incidence of Class III malocclusion was composed of a 
sample with 79% of the milder type I form of OI. [47] Other studies that found a higher 
incidence of malocclusion, also had a higher percentage of the more severe OI phenotypes in 
their sample. [25, 26, 41] These results support the theory that the more severe phenotypes of 
OI seem to produce more severe craniofacial abnormalities. 
 In addition to the high proportions of Class III malocclusion in the OI population, there 
is also a high degree of lateral openbite and posterior crossbite.  [27] Interestingly enough, 
lateral openbites are extremely rare in the general population. [26, 27] However, O’Connell 
and Marini found a 27% incidence of lateral openbite in Type III OI patients and 33% in 
patients with type IV.  He also observed that the severity of the lateral openbite seems to 
increase with age.  Within the 40 patient sample, none of the children younger than 9 years of 
age experienced posterior openbites whereas 46% had a either unilateral or bilateral posterior 
openbite after that age. [26]  
Other features are also commonly found in the OI population. Posterior crossbites were 
present in 65% of a heterogeneous OI sample by Schwartz & Tsipouras, whereas O’Connell 
and Marini found 38% of Type III OI patients and 47% of Type IV OI patients possessed this 
debilitating feature. [25, 26] OI patients also have an increased number of impacted teeth, 
permanent tooth agenesis and a high prevalence of ectopic eruption of first and second molars. 
[23, 25-27, 39, 41, 47]  
 
Etiology 
The same bony defects that cause malformed long bones in OI patients seem to also affect the 
craniofacial complex. There is an aberrant growth pattern of the upper and lower jaws that 
results in abnormal facial characteristics and severe malocclusion. [42] The typical 
craniofacial features observed are: triangular face, maxillary hypoplasia, mandibular 
prognathism, basilar invagination and broad forehead. [18, 26, 43] The etiology of these facial 
characteristics seems to be the increased bone fragility, which changes bone morphology, 
function and subsequently the growth pattern in these patients. [43] 
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The inability of the poor-quality bone to withstand the weight of the brain and/or head 
causes changes in bone morphology and its growth pattern. [18] According to Moss’ 
functional matrix theory, growth is highly dependent on function and any change in the latter 
will have considerable consequences on the former. [48] In OI patients, the weight of the head 
on the osteoporotic bone of the cervical area creates a basilar invagination, which will change 
the patient’s posture and functional capacities. Subsequently, growth in the craniofacial 
complex will be altered.  [18, 26, 43] The result will depend on the phenotypic severity of the 
OI syndrome. [17, 39, 40, 49, 50]  
OI patients develop more severe malocclusions than the general population. [27] 
Researchers claim that the typical malocclusion associated with the syndrome is primarily 
caused by maxillary hypoplasia, mandibular protrusion or a combination of the two.  [19, 25, 
26, 39, 41, 42, 51] When examining dental casts and cephalometric radiographs of OI patients, 
the maxilla is usually short in length and the mandibule is either normal in length or slightly 
shorter. These findings lead to the assumption that the Class III skeletal pattern is primarily 
due to a midface hypoplasia. [42, 43] Other features of the craniofacial growth include: a 
strong closing growth rotation of the mandible, a short condyle, underdeveloped alveolar 
bones in both jaws, and a decrease in vertical lower face height. The decrease in vertical 
growth seems to be the most pronounced growth abnormality in the craniofacial aspect of the 
syndrome. [43] Therefore, the Class III dentoskeletal malocclusion present in OI patients 
seems to be caused by a smaller than normal upper and lower jaw, an increased closing growth 
rotation of the mandible and a decreased vertical facial development. [41, 43] 
In addition to a Class III malocclusion, there is a high incidence of lateral openbites, 
anterior/posterior crossbites and impacted teeth.  Lateral openbites are extremely rare in the 
general population, and can be particularly debilitating in OI patients.  The high incidence of 
this feature in the OI population could be explained by an abnormal vertical dentoalveolar 
development and a lack of dental compensation.  [26] The high incidence of anterior and 
posterior crossbites seems to be created by the disharmony resulting from a hypoplastic 
maxilla opposed by a normal mandible.  [42] 
At present, the reason for the increased incidence of malocclusion present in the OI 
population is unknown.  However, a multifactorial process is surely the key to understanding 
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the variable craniofacial phenotypes of this syndrome.  Longitudinal prospective studies in this 
area of the OI syndrome are needed. [26] 
 
Treatment 
Despite the frequent functional and esthetic dental aberrations in OI patients, major treatments 
such as bone augmentation, orthodontics and orthognathic surgery are extremely rare in this 
population.  [51] Very little has been published about orthodontic treatment in these patients 
and the only type of data available is in case report format.  There are no controlled trials 
researching the outcomes of orthodontic treatments with or without orthognathic surgery in 
this patient population, nor is there any focusing on the variability in orthodontic outcomes in 
OI patients treated with bisphosphonates. [46] Nevertheless, the severe malocclusions seen in 
patients with this syndrome usually requires a combined orthodontic/surgical approach. [45] 
Furthermore, some authors have recently succeeded in doing osteodistraction and bone 
augmentation in these patients despite the morbidity of osseous surgery associated with the OI 
syndrome. [51] 
 
Traditional orthodontics  
Orthodontic therapy seems to be possible in the OI population, but there are only a few 
documented cases in the literature. More knowledge on this subject could be very useful 
because there are many facets of the OI syndrome that can become problematic during an 
orthodontic treatment.  More specifically, the poor quality of the bone, the presence of 
dentinogenesis imperfecta and treatment with bisphosphonates may make traditional 
orthodontics very difficult.  
 Successful orthodontic therapy is dependent on the bone remodeling process.  In order 
for tooth movement to be effective, osteoblasts and osteoclasts need to perform their role 
adequately around the periodontal ligament.  Osteoblasts are the bone-forming cells, while 
osteoclasts are the bone-resorbing cells.  The cycle of bone formation and resorbtion provides 
the very important balance usually seen in bone remodeling. [34] As previously stated, 
osteoblasts in OI patients do not function normally and the quality of the bone formed is poor. 
[2] In addition, in patients treated with bisphosphonates, osteoclast activity is inhibited. [31, 
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34]  Thus, the bone remodelling process is disrupted on many levels in the OI patient treated 
with bisphosphonates.  Since bone remodeling is essential for orthodontic therapy, the changes 
in bone metabolism can decrease the amount and rate of tooth movement achieved in these 
patients. [52] The magnitude and duration of the orthodontic forces may have to be adjusted in 
order to counterbalance the deficiency in collagen production created by the syndrome and the 
decreased bone resorption caused by bisphosphonate therapy. [39]  
 Patients with OI combined with dentinogenesis imperfecta may also present another 
challenge for the orthodontist.  Due to a qualitative abnormality in the dentin, the enamel in 
patients with a dentinogenesis imperfecta phenotype usually fractures very easily. [23, 26] 
These fractures can cause significant amounts of attrition and can lead to early tooth loss. [26] 
The adhesive forces of orthodontic bracketing may not be strong enough to withstand normal 
intra-oral forces and regular debonding can cause significant damage to these teeth. Bands 
with welded brackets can be used when the enamel is not strong enough for regular bracketing 
procedures. [46] Dentinogenesis imperfecta may complicate orthodontic therapy, but it is 
definitely still possible in these patients. 
 In the future, researchers should document more cases of orthodontic therapy in this 
patient population. Recent functional therapy with a Frankel Type III appliance has shown 
promising results. [43] If appliance therapy is successful and started at the right time, the need 
for orthognathic surgery may decrease in patients with OI.  
 
Orthognathic surgery 
Orthognathic surgery, such as maxillary advancement and mandibular set-back, has been 
successful in many patients with OI and is often combined with traditional orthodontics. A 
diagnosis with this syndrome does not seem to be a contraindication for a surgical 
intervention; however, great care must be taken when treatment planning, explaining the 
procedure to the patient and obtaining informed consent. [46, 53] Several authors have written 
case reports detailing maxillofacial surgery on OI patients, and claim to have achieved 
acceptable results, improving both function and esthetics. [40, 46, 49, 50, 53, 54]  (Figure 18 
and 19) 
Orthognathic surgery in OI patients has proven to be extremely variable.  Some are 
uneventful, while others can lead to unfavourable osteotomy fractures, massive hemorrhage 
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and respiratory distress. [44, 46, 49] Remarkably, the most severe sequelae do not seem to 
correspond to the most severe clinical phenotypes of the syndrome. [46, 49, 50] Complications 
seem to arise more when performing a Le Fort I maxillary osteotomy when compared to 
mandibular procedures. To help prevent a negative surgical experience, it is very important to 
properly diagnose a patient with OI, especially with a mild phenotype, and incorporate this 
 
 
Figure 18: Pre-orthognathic surgery photos in a woman with OI and a Class III malocclusion [46] 
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Figure 19: Post-orthognathic surgery photos in a woman with OI and a Class III malocclusion [46] 
 
diagnosis in the treatment planning process. [53] Great care must be taken to minimize the 
tendency for unfavourable fractures due to poor bone quality and thin maxillary and 
mandibular walls. [53, 55]  
Despite the increased bone fragility in OI patients, previous studies have shown that 
there is adequate bone healing after orthognathic surgery.  [19, 40, 51] However, Rauch et al. 
have demonstrated that abnormal bone remodelling exists in all OI patients. [16] 
Consequently, Tashima et al. recommend intermaxillary fixation for up to 5 to 6 weeks to 
prevent fracture during the healing period.  [53] Successful surgery in OI patients is definitely 
possible, but the surgeon must keep in mind that the chances of encountering complications 
are more common in this subset of patients. [17, 53, 54]  
 
Osteodistraction  
Osteodistraction of the maxilla is a viable treatment alternative that can decrease the number 
of unfavourable fractures that occur during conventional orthognathic surgery in OI patients. 
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[51] Since most complications occur during the down-fracture of a Le Fort I osteotomy, 
osteodistraction has been proposed to replace this part of the surgery. [51, 53] Bone biopsy 6 
months after osteodistraction and 4 months after augmentation showed adequate callus 
formation and good bone healing. These results are very promising when trying to diminish 
complications observed during orthognathic surgery. [51] 
 
Conclusion 
Patients with OI have been identified as a “high-risk group for the development of 
malocclusion”. [26, 39] There is a higher prevalence of Class III molar occlusion, posterior 
and anterior openbite, crossbite and impacted teeth in these patients. [25-27] In addition, 
considerable variation exists in the expression of the dental and craniofacial phenotype within 
the different types of OI as well as in patients with the same collagen type I abnormality. [18, 
25]  Due to the extreme variability in the phenotype of the syndrome, every time an OI patient 
is treated, he/she should be viewed as a unique case with a wide range of possible treatment 
options.  [46] Whatever treatment is chosen, a multidisciplinary approach should be adopted in 
order to optimize function and esthetics, as well as minimize any adverse consequences. [45] 
More importantly, diagnosis of the milder OI type I patients must be done prior to any 
decision with regards to treatment, in order to prevent any avoidable adverse consequences.  In 
the future, the characteristic malocclusion present in OI patients may be used as an additional  
diagnostic feature. 
 
 
  
 
Hypotheses and study aims 
Purpose  
Osteogenesis imperfecta is a connective tissue disorder characterized by a hereditary defect in 
the production of Type I collagen. [2, 5] Patients affected by OI are susceptible to spontaneous 
bone fractures and may show a number of other defects, such as joint laxity, hearing 
impairments, malformed long bones, growth deficiency, muscle weakness, blue sclera, 
dentinogenesis imperfecta and/or malocclusion.  The syndrome is extremely heterogeneous, 
producing a variety of phenotypes ranging from clinically undetectable to perinatal lethal.  [2] 
In fact, the milder forms of the syndrome are sometimes extremely difficult to diagnose; thus, 
more must be done to aid the diagnosis and classification of this debilitating disease.   
It seems that the same disease pathway that creates the severe skeletal deformity in 
these patients, also creates growth disturbances in the craniofacial complexe. [18, 39]  
Consequently, there is an increased incidence of Class III molar occlusion, posterior and 
anterior openbite, and posterior and anterior crossbite. [25-27] The aim of this study is to 
evaluate whether the severity of the malocclusion present in the OI population is proportional 
to the severity of the systemic bone disease. If so, the malocclusion present may serve an 
important diagnostic role when trying to identify and classify the multiple forms of this 
syndrome. 
 
Study aims  
The primary aim of this study is to compare the severity of the malocclusion present in OI 
patients with the severity of their systemic bone disorder. The study aim will be achieved by 
fulfilling the two following objectives: 
 
1. The malocclusion observed in a retrospective examination of OI patients will be 
quantified using the Discrepancy Index at one point in time. 
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2. The severity of the malocclusion quantified with the DI will be compared to other 
variables that characterize the severity of the OI syndrome (OI type, height z-score, 
type of genetic mutation)  
 
The secondary aim of this study is to evaluate whether the severity of the malocclusion present 
in OI patients changes with time. The secondary study aim will be achieved by fulfilling the 
following objective: 
 
1. The discrepancy index for a subgroup of OI patients will be tabulated at several points 
in time in order to determine the longitudinal progression of the malocclusion. 
 
Hypothesis 
The hypothesis for the primary study aim is as follows: 
Research Hypothesis: The severity of the malocclusion observed in OI is related to the 
severity of the systemic bone involvement.  As the severity of the malocclusion increases, 
there will be : 
• A decrease in height  
• An increase in the presence of the more severe types of OI (Type I < Type IV, V, VI, 
VII < Type III < Type II) 
• An increase in the more severe genetic mutations 
 
Null Hypothesis: The severity of malocclusion in OI is unrelated to the severity of the 
systemic bone involvement. 
 
The hypothesis for the secondary study aim is as follows: 
Research Hypothesis: The severity of malocclusion in OI increases as the child ages. 
Null Hypothesis: The severity of malocclusion in OI does not increase with time. 
 
 
  
 
Materials and methods 
Study design and setting 
A retrospective observational study was conducted involving 3 administrative facilities: the 
Montreal Shriners Hospital, the Montreal Children’s Hospital, and the University of Montreal. 
The physicians at the Shriners Hospital follow the largest cohort of patients with OI in North 
America. Consenting patients seen at the Shriners are referred to the Montreal Children’s 
Hospital dental clinic, where complete dental examination is done and required treatment is 
provided.  Consequently, over the past decade, the dental clinic has documented oral records 
for over 70 OI patients. Whenever possible and/or appropriate, intra-oral and extra-oral 
findings, panoramic and cephalometric radiographs, intra- and extra-oral photos, and dental 
casts with bite registration were obtained. 
The ethics review board of the Montreal Children’s Hospital approved the study (study 
13-486-PED).   Scientific merit and approval was given by the review board at the University 
of Montreal. Informed consent was obtained from the legal guardians and/or patients when 
age-appropriate. 
 
Subjects 
The study population consists of 73 patients with varying types of OI who were referred to the 
Montreal Children’s Hospital by the Shriners Hospital between the period of July 2006 and 
July 2013.  
 
Inclusion criteria for the study sample were defined as:  
 
• definite diagnosis of OI 
• regular follow-up at the Montreal Shriners Hospital 
• adequate casts and radiographs available 
• informed consent with regards to participation in the study 
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Exclusion criteria were set as: 
 
• a history of orthodontic treatment 
• a history of orthognathic surgery 
• presence of an inadequate bite registration 
• several missing teeth (>8 missing teeth) 
 
All OI patients had received or were still receiving intravenous bisphosphonate therapy.  
 
Variables 
Information regarding the following variables was collected: 
• Age 
• Gender 
• Presence of dentinogenesis imperfecta 
• Height z-score 
• OI type 
• Mutated gene  
• Type of genetic mutation 
• Position of amino acid substitution 
• Molar relation 
• Discrepancy Index (DI) 
 
All information, except for the molar relationship and DI score, was collected through chart 
review at the Shriners Hospital in Montreal.  Height measurements had been converted to age- 
and sex-specific Z-scores on the basis of reference data published by the Centers for Disease 
Control and Prevention. [12, 56] For the genetic mutation type, genomic DNA had been 
isolated in the laboratory of Dr. Frank Rauch at the Montreal Shriners Hospital from either 
blood or saliva using standard extraction methods. [12] The types of genetic mutations 
identified in this sample were: triple helical defect, protein complex defect, splice mutation, 
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stop codon, or was unidentified. Sequencing had been done with a polymerase chain reaction 
using primers.  Helical mutations were numbered according to the position of the mutated 
amino acid within the triple helix of each alpha chain. [12] The mutated genes identified in 
this sample were: COL1A1, COL1A2, CRTAP, SERPINF1 or was unidentified. The OI 
classification by type had been done by the Montreal Shriners Hospital based on clinical, 
radiographic and genetic information. The types of OI present in this sample were: type I, III, 
IV, VI. 
Molar relationship was determined while calculating the DI of the malocclusion using 
each patient’s dental cast at the Montreal Children’s Hospital.  The severity of the 
malocclusion was assessed using the DI scoring system by evaluating the overjet, overbite, 
open bite, crowding, occlusal relationship, crossbite and presence of missing teeth. [38] The 
cephalometric component of the DI was not included in the analysis as lateral cephalograms 
were not possible for patients with severe craniofacial deformations. The DI scores for each 
component were measured by one investigator, and then tabulated to give a final DI score of 
the malocclusion. (Figure 20) Measurements were taken using a Carrera Precision CP7908 8-
inch fractional digital LCD caliper from Whitworth.    
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Figure 20: DI scoring sheet [38] 
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Statistical analysis  
Descriptive statistics are presented for demographic and clinical characteristics. DI 
measurements in 56 OI patients at one point in time are presented as medians for continuous 
variables and proportions for categorical variables. Statistical significance was established as p 
< 0.05. 
 For the primary aim, DI measurements were compared with height z-score, genetic 
mutation and classification type for univariate analysis with one-way ANOVA if the data 
followed a gaussian distribution and via Spearman correlation, Mann Whitney U test and 
Kruskal-Wallis test for non-normally distributed data. Bonferoni adjusted p-values were 
calculated when indicated.   
For the secondary aim, Spearman correlations for repeated measures were used to 
characterize the change over time in a sample of 20 OI patients measured at two points. 
The intra and inter reliability of the quantified malocclusion (Discrepancy Index) were 
assessed by calculating the Kappa score. Fifteen subjects were measured twice by the same 
rater (intra-rater reliability) and twenty-nine subjects were measured once by another rater 
(inter-rater reliability). 
All calculations were performed using Statistical package for social sciences (SPSS, 
version 20.0, Chicago, IL, USA) 
 
 
 
 
 
 
 
 
 
 
 
  
 
Results 
Of the 73 OI patients referred to the Montreal Children’s Dental Clinic between July 
2006 and July 2013, 56 fulfilled the eligibility criteria. (Figure 21)  
 
	  
Figure 21:Inclusion and exclusion criteria for sample size 
 
 
 
 
 
 
 
 
 
 
 
 
 
73	  patients	  accepted	  to	  have	  a	  dental	  examination	  and	  consented	  to	  participate	  in	  the	  study	  
13	  patients	  =	  inadequate	  bite	  registration	  
1	  patient	  =	  >	  8	  missing	  teeth	  	  	  
2	  patients	  =	  inadequate	  follow-­‐up	  
1	  patient	  =	  mistaken	  diagnosis	  
	  Sample	  size	  =	  
56	  patients	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Table 4: Descriptive characteristics of OI study sample (n = 56) 
 	  	  
Gender  Gene Mutated, n (%)   
Males, n (%) 28 (50%)     
   COL1A1 28 (50.0%) 
Age  
	  
COL1A2 23 (41.1 %) 
Years, (mean+SD) 10.82 + 3.87 CRTAP   1 (1.8%) 
Years, n (%)  LEPRE1   1 (1.8%) 
0-7 12 (21.4%) SERPINF1   2 (3.6%) 
8-13 32 (57.1%) Unidentified   1 (1.8%) 
14-21 12 (21.4%)     
    Type of genetic mutation, n(%) 
Molar relationship, n (%)    	  	  
Class I 13 (23.2%) Triple helical defect 41 (73.2%) 
Class II   6 (10.8%) Protein complex defect   4 (7.1%) 
Class III 36 (64.2%) Splice mutation   9 (16.1%) 
No class   1 (0.2%) Stop codon   1 (1.8%) 
    Unidentified   1 (1.8%) 
Dentinogenesis Imperfecta   	  	  
Affected, n (%) 45 (80.4%) Position of amino acid substitution 
      	  	  
OI Type, n (%)  1-499 14 (37.71%) 
I   9 (16.1%) 500-999 18 (43.61%) 
III 13 (23.2%) 1000-1500   9 (40.56%) 
IV 32 (57.1%)   	  	  
VI   2 (3.6%) Height Z-score   
    Z-score, (mean+SD) -3.37 + 2.33 
	  	   	  	   Z-score, percentiles 	  	  
	  	   	  	   25	   -5.46 
	  	   	  	   50	   -3.67 
	  	   	  	   75 -1.77 
      	  	  
n= number of patients 
	   	   	  SD= standard deviation 
	   	   	   
Table 4 shows selected demographic statistics of the study population.  The sample 
was composed of 50% males. The mean age was 10.82 (+ 3.87) years, with a range 
(minimum-maximum) of 4-21 years.  The great majority (64.2%) of OI patients presented 
with a class III malocclusion.  One patient could not be classified with Angle’s molar 
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occlusion because the lower first molars were absent.  In addition, the bulk of the OI patients 
(45 of 56 patients) were diagnosed with OI Type III (23.2%) or Type IV (57.1%), which 
produce the more severe phenotypes of the syndrome compatible with survival.  There are no 
patients with OI Type II in the sample because this type of OI is perinatally lethal.  Most 
subjects (51 of 56 patients) had genetic mutations in either COL1A1 (50%) or COL1A2 
(41%), which is consistent with the literature to date. [6, 9] One patient had an unidentified 
genetic mutation and the other patients (4 of 56 patients) had recessive mutations in CRTAP, 
LEPRE1 and SERPINF1. The majority of the patients (41 of 56 patients) had an amino acid 
substitution, which created a triple helical defect in the procollagen molecules.  
 
Malocclusion Severity 
The total DI scores broken down into individual components are presented in Table 5. The 
values represent the frequency that a particular facet of the malocclusion was seen in the OI 
sample, as well as the median [minimum, maximum] total DI score (33.5 [1,109]). The three 
major contributing factors to the DI score for OI patients were discrepancies in overjet, 
lingual posterior crossbite and occlusion. Specifically, we observed that 51/56 OI patients 
(91.1%) had a disparity in overjet.  Lingual posterior crossbite was present in 50/56 OI 
patients (89.3%) and occlusal relationships were divergent from normal in 43/56 OI patients 
(78.2%). No OI subjects presented with a buccal posterior crossbite. 
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Table 5: DI scores of OI study sample (n = 56) 
 
Measured parameters DI Scores 
  (Median [min, max])  
  	  	  
Total 33.5 [1,109] 
    
Overjet 6 [0, 49] 
    
Overbite 0 [0, 5] 
    
Anterior openbite 1 [0, 22] 
    
Lateral openbite 1 [0, 40] 
	  	     
Crowding 1.5 [1, 7] 
    
Occlusion 8 [0, 10] 
    
Lingual posterior crossbite 3 [0, 7] 
    
Buccal posterior crossbite None 
	  	     
Other 2 [0, 16] 
n= number of patients 
	  min = minimum 
max = maximum 
	   
 
Spearman correlations were done to determine the greatest statistically significant 
correlations between the total DI score and each individual component. (Table 6) The highest 
correlations (p<0.0001) in this population were seen between total DI and overjet, lateral 
openbite, lingual posterior crossbite, occlusion and the others category. Also, patients with 
dentinogenesis imperfecta had statistically significant higher DI scores according to the 
Spearman correlation (p = 0.017). 
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Table 6: Spearman correlation between DI score and individual components 
    	  	  
DI Components Spearman’s Rho p-value 
      
      
Overjet 0.734 0.0001 
      
Overbite -0.015 0.91 
      
Anterior openbite 0.387 0.003 
      
Lateral openbite 0.769 0.0001 
	  	       
Crowding 0.089 0.515 
      
Occlusion 0.834 0.0001 
      
Lingual posterior 
crossbite 0.646 0.0001 
      
Buccal posterior 
crossbite − − 
	  	       
Other 0.625 0.0001 
 	   	   
The kappa scores for inter-rater and intra-rater reliability for DI measurements were 
0.943 and 0.992 respectively.
  
 
DI score vs OI Type 
The DI score increased with increasing severity of OI type (p=0.001).  More specifically, OI 
type I had a median [minimum, maximum] DI score of 12 [3, 24], followed by OI type IV / 
VI with 38.5 [1, 89] and OI Type III with 53 [6, 109]. (Figure 22) Bonferroni adjusted P-
values for the 3 groups showed that the major differences existed between OI Type I and 
Type III (p=0.001), followed by OI type I and type IV/VI (p=0.008).  No statistical difference 
was found in the DI score between OI type III and and OI type IV/VI.  
 
 
 
Figure 22: Discrepancy Index vs. OI Type 
 
In addition, there is a statistically significant correlation between the increase in DI 
and an increase in OI severity. (Gamma = 0.0530, p<0.001) 
When age is added as a covariable using the Brunner-Langer test, the DI score was 
also found to increase with increasing severity of OI type (p<0.0001). The p-value for the co-
variable of age was found to be 0.035. Bonferroni adjusted P-values for the 3 groups also 
demonstrated that the major differences existed between OI Type I and Type III (p=0.0001), 
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followed by OI type I and type IV/VI (p=0.0001); however, there was no statistical difference 
found in the DI score between OI type III and and OI type IV/VI (p=0.6229).   
 
DI score vs. Height z-score  
The average height z-score (mean + standard deviation) of our study was sample was -3.37 + 
2.33.  All the patients included in our study sample had a height z-score below 0, 
demonstrating that their heights are below those expected in age- and sex-matched healthy 
controls.  The DI score increased with decreasing height z-score (Spearman rho = -0.521, 
p<0.0001).  (Figure 23)  
 
 
Figure 23: Discrepancy index (DI) vs. height z-score 
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DI scores vs. Genetic mutation 
Of the 56 OI patients analyzed, 28 had a mutation in COL1A1 and 23 had a mutation 
in COL1A2. The DI score was significantly lower in patients with genetic mutations in the 
COL1A1 gene than in patients with mutations in COL1A2 (p=0.021). Median [minimum, 
maximum] DI scores for patients with COL1A1 mutations was 25 [1, 109], while COL1A2 
mutation was 43 [12, 89].  (Figure 24) 
  
 
 
Figure 24: Discrepancy index vs. genetic mutation 
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When looking at the type of mutation present in the OI patients analyzed, 41 had a 
triple helical defect as opposed to 9 patients who had a splice defect. Patients with an amino 
acid substitution had significantly higher DI scores than patients with splice mutations (p= 
0.020).  Median [minimum, maximum] DI scores for patients with triple helical defects was 
38 [1, 109] as opposed to splice mutations, which had a median [minimum, maximum] DI 
score of 14 [3, 58]. (Figure 25) 
 
 
 
Figure 25: Discrepancy index vs. type of genetic mutation 
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When helical defect mutations were analyzed more closely, it was discovered that 
there were 14 OI patients with a mutation in the first 499 amino acids in the pro-α 
poplypeptide, 18 patients with a mutation between amino acid 500-999, and 9 patients with a 
mutation between amino acid 1000-1500. When investigating the effect of the position of the 
amino acid substition in the procollagen chain on the DI score, no statistically significant 
difference was found. (Figure 26 and 27) 
 
 
 
Figure 26: Discrepancy index vs. position of genetic mutation 
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Figure 27 : Discrepancy index vs. position of amino acid substitution 
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Longitudinal Analysis 
Of the 73 OI patients referred to the Montreal Children’s Dental Clinic, 34 patients had 
several dental casts that were available for longitudinal analysis.  However only 20 patients 
fulfilled the eligibility criteria.  (Figure 28) The time interval (mean + SD) between the two 
dental cast impressions was 1.46 (+ 0.75) years.  
 
	  	  	  	  
Figure 28: Inclusion and exclusion criteria for longitudinal analysis 
 
 
 
 
 
 
 
 
 
34	  patients	  with	  more	  than	  one	  dental	  cast	  
3	  patients	  had	  previous	  orthodontic	  treatment	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  patient	  had	  orthognathic	  surgery	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10	  patients	  had	  an	  inadequate	  bite	  registration	  
20	  patients	  with	  more	  than	  one	  cast	  to	  analyze	  longitudinally	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Table 7: Descriptive characteristics of OI longitudinal study sample (n = 20) 
Gender   Gene Mutated, n (%)   
Males, n (%) 8 (40%)     
    COL1A1 11 (55%) 
Molar relationship, n (%)  COL1A2   9 (45%) 
Class I   6 (30%)     
Class II   2 (10%) Type of genetic mutation,n(%) 	  	  
Class III 12 (60%)   	  	  
   Triple helical defect 17 (85%) 
Dentinogenesis 
Imperfecta   Splice mutation   3 (15%) 
Affected, n (%) 16 (80%) 	  	   	  	  
    Position of amino acid substitution, n (%) 
OI Type, n (%)   
 
	  	  
I   4 (20%) 1-499 7 (35%) 
III   3 (15%) 500-999 4 (20%) 
IV 13 (65%) 1000-1500 6 (30%) 
   Missing (splice mutations) 3 (15%) 
	  	   	  	       
n= number of patients 
	   	   	  SD= standard deviation  
	   	   
Table 7 shows selected demographic statistics of the 20 patients included in the 
longitudinal analysis.  The sample was composed of 40% males. Again, the majority (60%) of 
OI patients presented with a class III malocclusion.  In addition, the bulk of the OI patients 
(16 of 20 patients) were diagnosed with OI Type III or Type IV, which produce the more 
severe phenotypes of the syndrome.  All subjects had genetic mutations in either the COL1A1 
or COL1A2.  The majority of the patients (17 of 20 patients) had an amino acid substitution, 
which created a triple helical defect in the procollagen molecules. 
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Table 8: Age, DI and height at T1 and T2 (n=20) 
  	    T1 T2 p-­‐value	  
Age      	  	  
Years, (mean + SD) 9.62 + 3.17 11.08 + 3.40 	  	  
      	  	  
Discrepancy Index     	  	  
Score, (median [min-max]) 25.5 [1-77] 35 [1,66] 0.05	  
      	  	  
Height Z-score     	  	  
Z-score, (mean + SD) minus2.91 + 1.95 minus2.8 + 1.99 0.557	  
      	  	  
n= number of patients min = minimum 	  	  
	  SD= standard deviation max = maximum 
	   	   
The age, DI and height z-score were recorded at two time points (T1 and T2).  At T1, 
the age distribution (mean + SD) was 9.62 (+3.17) years, with a range (minimum-maximum) 
of 4-17 years. The median [minimum, maximum] total DI score at T1 was 25.5 [1,77]. At T2, 
the age distribution (mean + SD) was 11.28 (+ 3.47) years, with a range (minimum-
maximum) of 5-19 years.  The median [minimum, maximum] total DI score increased 
significantly to 37 [1,66]. (Table 8) Fifteen patients had an increase in DI, three subjects had a 
decrease in DI, and two subjects exhibited no change. 
The change in DI over time was found to be statistically significant (p=0.05). The 
change in overjet, as well as the change in lingual posterior crossbite was also found to be 
statistically significant (p=0.05 and p=0.009).  The change over time in the other DI 
components was not statistically significant. 
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Figure 29: Change in DI correlated vs Age at T1 
 
Spearman correlations were done to determine the significant associations between the 
time between the two appointments and the change in total DI score, as well as each 
individual component. (Figure 29) The only statistically significant correlations existed 
between the change in total DI score (Spearman rho=0.563, p=0.01) and the change in 
anterior openbite (Spearman rho=0.466, p=0.038).  Thus, as more time passes, there is more 
of an increase in total DI score as well as anterior open bite score. 
 
  
 
Discussion 
Overview 
Within the limits of the study, the results suggest that the malocclusion characteristic of OI 
patients is linked to the severity of the syndrome. The severity of the malocclusion present in 
56 OI patients was quantified using the Discrepancy Index (DI) and the median [minimum, 
maximum] total DI score was found to be 33.5 [1,109]. The three factors that contributed most 
to the malocclusions in this OI sample were discrepancies in overjet, lingual posterior 
crossbite, and the molar relationship.  Lateral openbite also demonstrated a high correlation 
with a higher DI severity. Moreover, when the DI score was compared to three factors that 
characterize the severity of the OI syndrome (height z-score, classification type and genetic 
type), the higher DI scores were associated with a decrease in height z-score and an increase in 
the more severe OI Types. In addition, this is the first study to analyze the malocclusions of OI 
patients in a longitudinal manner. The longitudinal analysis of 20 OI patients demonstrated a 
statistically significant increase in DI over time.  
As Rizkallah et al. discovered in 2013, OI patients are a high-risk population for severe 
malocclusion.  This conclusion was re-confirmed with our study sample, taken from the same 
OI population as the Rizkallah group. [27] In our study, not only was the malocclusion 
severity found to be increased (33.5 [1,109]), there was a distinct over-representation of Class 
III malocclusion, negative overjet and lingual posterior crossbite.  Forty-five OI patients 
(64.2%) had a Class III molar relationship as compared to the 3 to 8% observed in the general 
population of previous studies. [26, 36] Our results are similar to other authors who have also 
observed the high number of Class III molar relationships present in the OI population.  
(Figure 30) Schwartz and Tsipouras found a 67% Class III relationship in their 28 OI patient 
sample, O’Connell & Marini found a 70% Class III relationship in 40 OI patients and Chang 
et al. found a 62.5% Class III relationship in 16 OI patients. [25, 26, 41] The maxillary and 
mandibular arch discrepancy present in the OI phenotype not only creates a Class III molar 
relationship, but also a high incidence of severe anterior and posterior crossbites.  Our study 
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not only looked at the type of malocclusion characteristic of the OI population, it also 
demonstrated that this malocclusion correlates with the syndrome’s phenotypic severity. 
 
 
Figure 30: Anterior crossbite and class III malocclusion in an OI patient (courtesy of the Montreal Children’s 
Hospital) 
 
Much controversy exists concerning the maxillary and mandibular arch discrepancy 
present in the OI population.  In fact, the etiology of the malocclusion remains unclear.  Some 
researches have proposed the problem originates from a prognathic mandible and others, a 
hypoplastic maxilla. [41, 43]  Regardless of the etiology, often the maxilla of an OI patient is 
much smaller in relation to the mandible, creating severe anterior and posterior crossbites.  
Our sample presented with a median [minimum, maximum] DI score for overjet of 6 [0,49].  
When using the DI, negative overjet is tabulated as 1 point per millimeter per tooth in anterior 
crossbite.  Thus, a median of 6 points with a range of 0-49 shows the high incidence of 
negative overjet in the OI population as well as the great variability within patients. Lingual 
posterior crossbites ranked as the third highest facet of the OI malocclusion, with a median 
[minimum, maximum] DI score of 3 [0,7].   Both anterior and posterior crossbites can greatly 
impede proper oral function and are difficult to treat without surgical intervention when 
severe. 
One of the DI measures with a highly statistically significant correlation with large 
total DI scores was the lateral openbite. (Figure 31) Probably the most debilitating facet of the 
malocclusion, the lateral openbite had a median score of 1 [0,40].  The high range shows the 
great variability in the presence of lateral open bite; however, the high correlation with the DI 
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shows that when the DI score was elevated, so was the presence of lateral openbite.  The 
common combination of mandibular pseudo-prognathism and deficient contact between upper 
and lower posterior teeth produces a debilitating malocclusion, which may hinder oral 
function for OI patients. 
 
 
Figure 31: Severe lateral openbite in an OI patient  (courtesy of the Montreal Children’s Hospital 
 
The severity of the malocclusion in the OI population correlated positively with the 
height z-score and classification type of the OI syndrome.  The factor that correlated the most 
with the DI score was the patients’ height. Analysis with spearman correlation demonstrated 
that as the DI score increased, the height z-score decreased. Thus, the severe phenotypes that 
impede normal skeletal growth and development also create the more debilitating 
malocclusions.  In addition, the patients with a type of OI associated with the more severe 
phenotypes also possessed the higher DI scores. The DI score increased with increasing 
severity of OI type. More specifically, the null hypothesis was rejected when comparing the 
DI score of OI Types I and III, as well as of OI types I and IV/VI. No statistical difference 
was found in the DI score between OI type III and OI type IV/VI because usually these types 
produce phenotypes of similar severity.   
The relationship between the genetic type and the DI score is harder to extrapolate. In 
our study, the DI score was significantly lower in patients with genetic mutations in the 
COL1A1 gene than in patients with mutations in COL1A2. However, to date, there is no 
consensus regarding the link between the genotype and phenotype expressed in the OI 
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syndrome. Many researchers have tried to decipher the connection between the two with no 
success, but all agree that the OI phenotype is dependent on a multitude of factors.  According 
to Rauch et al, the clinical severity caused by an autosomal dominant mutation is governed by 
a multifactorial process which may be related to: “the type of α chain affected, the type of 
amino acid substituted for glycine and the position of the mutation within the α chain.” [11, 
12] Therefore, when analyzing the genetics of OI it does not suffice to merely look at the gene 
affected; the amino acid substitution and the position of the mutation on the α chain must be 
specified. We attempted to incorporate mutation position into our results to better understand 
the relationship between genotype and the malocclusion phenotype. However, no statistically 
significant difference was found between the mutation position and the total DI score.  
Perhaps with a larger sample size, this relationship can be re-explored.   
In addition, O’Connell & Marini have suggested the severity of the malocclusions 
present in OI patients actually increases with age.  In their sample, none of the children 
younger than 9 years had a posterior openbite, whereas 46% of the older children showed 
signs of this type of malocclusion. [26] In our study, we investigated a subset of 20 patients in 
a longitudinal manner at two points in time.  Although our sample size was quite small, we 
found that the DI score increases significantly over time in the majority of OI patients.  Only 
three subjects demonstrated a decrease in DI score.  Two of these subjects had a decrease of 
two points or less, whereas the third subject exhibited a decrease of 23 points.  However, the 
only two DI categories that decreased in this patient were the anterior open bite (4 points) and 
lateral openbite (20 points).  A logical explanation for this decrease would be the natural 
eruption of teeth that occurs during the mixed dentition, which may create a temporary open 
bite and contribute to an increased DI score. This patient’s malocclusion was most likely over-
estimated at the first time point. 
Overjet and lingual posterior crossbite were the only two DI components that increased 
significantly with time. This can be explained by the fact that the mandible continues to grow 
in the sagittal plane after the maxilla has ceased to grow in both the sagittal and transverse 
planes.  Thus, the findings in this study are consistent with patients who have a Class III 
skeletal malocclusion.  In addition, Spearman correlations demonstrated that as more time 
passes, there is more of an increase in DI scores and anterior open bite scores in OI patients. 
Thus, since we know that the maloclusion of OI patients tends to increase with time, 
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preventive strategies to modify growth in the hopes of reducing the malocclusion severity and 
morbidity is highly indicated. 
 
Study limitations  
Although this study had many strengths, there were also some limitations.  The number of 
patients treated at the Montreal Shriners Hospital is one of the largest in North America.  
Consequently, our sample size is larger than other comparable studies.  However, the study 
sample was not large enough to detect a correlation during some of the statistical analyses 
performed.  For example, a correlation between the position of the helical mutation and the 
severity of the malocclusion could not be adequately assessed due to insufficent power.  
Conversely, in our longitudinal analysis, a statistically significant increase in DI score was 
found even though our sample consistent only of 20 subjects.  
Another limitation of this study is that the sample is not representative of the actual OI 
population.  Patients that are followed by the Montreal Shriners Hospital are usually those 
with more severe phenotypes requiring bisphosphonate therapy. Type I OI is “the most 
common and mildest form” of the syndrome, whereas 80.3% of the patients in our study 
possessed OI Type III and Type IV. [14] Jensen & Lund found less severe malocclusions in 
their study, but their sample contained more OI Type I patients.  [18] Thus, the high 
prevalence of increased total DI scores in our study group could be explained by the higher 
degree of skeletal involvement in these OI types as compared to OI type I (19.7% of our 
sample).    
In addition, the treatment with intra-venous bisphosphonates could not be controlled for 
and produces a bias in this study. Bisphosphonates impair osteoclastic activity and consequently 
affect bone remodeling and growth. [2] As dental eruption and dentoalveolar development 
requires constant bone remodeling, it is possible that the reduced osteoclastic activity has a 
significant impact on posterior occlusal development. However, none of the subjects studied by 
Schwartz & Tsipouras, O’Connell & Marini, or Waltino-Siren et al, had received any treatment 
with bisphosphonates and similar malocclusions were present in their OI sample. [25, 26, 43] 
Their findings confirm our assumption that the facial growth impairment is part of the phenotype 
of OI and not bisphosphonate therapy. 
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Difficulties encountered 
Several obstacles arose during this research study.  The major obstacle was the lack of 
adequate bite registrations for many OI dental casts.  Without a proper bite registration, it is 
impossible to adequately evaluate the occlusion of most OI patients.  Usually placing models 
in maximal intercuspation could suffice; however, the occlusions seen in these patients are so 
irregular that a proper bite registration taken in centric relation is absolutely necessary.  The 
Montreal Children’s Hospital dental residents took bite registrations for the OI sample, and 
their possible inexperience as well as the young age and difficult cooperation of some patients 
may have lead to inaccurate registrations.  Consequently, 13 patients were removed from our 
sample, greatly reducing its size and leading to a decrease in power.   
Also, it was very difficult to accurately evaluate the presence of lateral openbite 
because most of our sample was in mixed dentition. The average age (mean + standard 
deviation) was 10.82 + 3.87 years and only 21.4% of our sample was above 14 years of age.  
Since canines, premolars and second molars are often still in eruption before 14 years of age, it 
was sometimes difficult to determine if a lateral openbite was present or if eruption was 
incomplete. 
Lastly, the radiographic component of the DI could not be incorporated into the 
analysis due to a lack of cephalometric radiographs for the majority of our study sample.   In 
OI patients, the weight of the head on the osteoporotic bone of the cervical area creates a 
basilar invagination, which will alter the patient’s posture and neck anatomy.  [18, 26, 43]  
The resulting deformity in the cervical area makes it quite difficult to take a cephalometric 
radiograph in patients that are severely affected.  Consequently, the total DI score that was 
calculated was underestimated since it lacks a major component of the malocclusion 
assessment.  
 
Future studies 
Future studies are definitely needed to broaden our knowledge of the extremely complex OI 
syndrome.  First and foremost, the classification of OI must be revisited. [18] The Sillence 
classification was made before the molecular basis of the syndrome was discovered.  [3, 12] 
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The subdivision of the four original types may have been necessary, but the intermingling of 
genetic and clinical classification is extremely confusing and inefficient. [2, 3, 6, 29]  
In addition, a greater understanding of the genotype and phenotype relationship is 
necessary in the hopes of better understanding the disease pathway of the OI syndrome.  
Future studies should investigate the different types of genetic mutations and their respective 
effects on the craniofacial complex.  According to Jensen & Lund, patients with a qualitative 
defect of collagen Type I were significantly more affected in their craniofacial region than 
patients with a quantitative defect, irrespective of the OI type. However, the disease 
progression is most definitely multifactorial since patients with identical collagen 
abnormalities did not present with the same craniofacial phenotype.  Jensen & Lund suggest to 
link cephalometric evaluation with biochemical analysis (fibroblast activity) in order to better 
characterize the phenotype and better understand the etiology of the malocclusion. [18] With 
the identification of the genetic and biochemical abnormalities in each patient, an 
improvement in diagnosis, classification and treatment of the various OI types may follow.  
Radiographic evaluation must be included in future studies in order to analyze the 
craniofacial abnormalities that develop in OI patients.  Previous research studies have 
attempted to look at cephalometric radiographs of OI patients.  In 2007, Chang et al. evaluated 
cephalometric radiographs of 16 OI patients and found several craniofacial abberrations 
present in his sample.  However, this study had a  small sample size and an exclusively Asian 
population; therefore the results may not be extrapolated to the general OI population. [41] In 
2005, Waltino-Siren et al. examined the lateral cephalograms of 59 OI patients. They found a 
normal SNB angle and normal measures for the Harvold jaw-size difference.  These ‘normal’ 
results seem surprising when one looks at the severe clinical Class III jaw relationships present 
in our study. They concluded that the landmarks used in cephalometric measurements were 
not positioned normally in OI patients; thus, the cephalometric analysis of OI patients is 
consistently inaccurate. [43] In the future, another type of cephalometric analysis may be used, 
such as the one created by Delaire.  In the latter, the analysis is based on the relationship of 
the maxillary facial bones to the cranium of the individual, which would have eliminated the 
previous inaccuracies.  [57] In addition, radiographic examination with CBCT to replace 
panoramic and cephalometric radiographs may be indicated.  CBCT provides much more 
information concerning craniofacial development then a regular panoramic and cephalometric 
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series.  Although there is a higher dose of radiation, Proffit states that CBCTs are indicated in 
syndromic patients, especially when the disease is progressive. [34] 
In conclusion, there are little studies that combine the genetic mutation, collagen type I 
defects and the result on skeletal development.  Also, those who have tried have limited 
sample sizes. [12] Since the disease pathway in OI is multifactorial and extremely 
heterogeneous, in order to discover the etiology of the OI phenotype, a study must be designed 
to take all the previously mentionned factors into account. All aspects of the somatic 
development must be assessed, including the craniofacial region.  Essentially, a prospective 
longitudinal study is required on this topic.  The malocclusions characteristic of the OI 
population are debilitating and extremely taxing on quality of life.  More must be done to 
determine the etiology of the disease pathway and redefine classification in order to improve 
treatment options.   
   
  
  
 
Conclusion 
Several authors have proposed that the severity of the malocclusion and facial characteristics 
seen in OI patients reflect the severity of the syndrome. [18, 19] Based on our study results, 
the malocclusion characteristic of OI patients seems linked to the severity of the syndrome. 
The higher DI scores were associated with a decrease in height z-score and an increase in the 
more severe OI Types. In addition, our longitudinal analysis demonstrated that malocclusion 
severity increases with age in OI patients. More specifically, the change in overjet, as well as 
the change in lingual posterior crossbite was found to be statistically significant.  In the future, 
longitudinal prospective studies will be needed to study the craniofacial features characteristic 
of the OI population in order to determine their etiology and possible treatment options in 
extreme cases. 
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